These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28472)

  • 1. Influence of pH on the interaction of cardiotonic steroids with sodium- and potasssium-dependent adenosine triphosphatase.
    Yoda A; Yoda S
    Mol Pharmacol; 1978 Jul; 14(4):624-32. PubMed ID: 28472
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
    [No Abstract]   [Full Text] [Related]  

  • 3. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate.
    Yoda A
    Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression by sodium, potassium or nucleotides of binding between cardiac steroid (digoxigenin) and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1979 Jul; 16(1):120-34. PubMed ID: 225651
    [No Abstract]   [Full Text] [Related]  

  • 5. Ouabain binding to sodium- and potassium-dependent adenosine triphosphatase: inhibition by the , -methylene analogue of adenosine triphosphate.
    Tobin T; Akera T; Hogg RE; Brody TM
    Mol Pharmacol; 1973 Mar; 9(2):278-81. PubMed ID: 4268124
    [No Abstract]   [Full Text] [Related]  

  • 6. A possible biochemical explanation for the insensitivity of the rat to cardiac glycosides.
    Allen JC; Schwartz A
    J Pharmacol Exp Ther; 1969 Jul; 168(1):42-6. PubMed ID: 4240031
    [No Abstract]   [Full Text] [Related]  

  • 7. Association and dissociation rate constants of the complexes between various cardiac aglycones and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1977 Mar; 13(2):352-61. PubMed ID: 140301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interaction of Na+, K+-ATPase with ouabain].
    Lishko VK; Malysheva MK; Poliakova NM
    Ukr Biokhim Zh; 1971; 43(1):17-24. PubMed ID: 4253955
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F; Mahmmoud YA
    Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. IV. Dissociation rate constants for complexes of the enzyme with cardiac oligodigitoxides.
    Yoda S; Sarrif AM; Yoda A
    Mol Pharmacol; 1975 Sep; 11(5):647-52. PubMed ID: 126365
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake of cardiac glycosides by rabbit and rat myometrium.
    Murthy RV; Kidwai AM; Daniel EE
    J Pharmacol Exp Ther; 1972 Jul; 182(1):166-78. PubMed ID: 4261223
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes.
    Yoda A; Yoda S; Sarrif AM
    Mol Pharmacol; 1973 Nov; 9(6):766-73. PubMed ID: 4271632
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding of digoxigenin to sodium- and potassium-dependent adenosine triphosphatase.
    Yoda A
    Mol Pharmacol; 1976 May; 12(3):399-408. PubMed ID: 132604
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible involvement of cardiac Na+, K+-adenosine triphosphatase in the mechanism of action of cardiac glycosides.
    Schwartz A; Allen JC; Harigaya S
    J Pharmacol Exp Ther; 1969 Jul; 168(1):31-41. PubMed ID: 4240030
    [No Abstract]   [Full Text] [Related]  

  • 15. The interaction of ouabagenin and (Na+ + K+)-ATPase in the presence of Na+, Mg2+, and ATP.
    Yoda A; Yoda S
    Mol Pharmacol; 1981 Jan; 19(1):62-7. PubMed ID: 6259513
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium- and potassium-dependent adenosine triphosphatase of electric organ: interaction with ouabain in situ, in a membrane fraction, and in the solubilized form.
    Zubler-Faivre L; Dunant Y
    Mol Pharmacol; 1976 Nov; 12(6):1007-18. PubMed ID: 137360
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of phospholipids in the binding of ouabain to sodium- and potassium-dependent adenosine triphosphatase.
    Taniguchi K; Iida S
    Mol Pharmacol; 1973 May; 9(3):350-9. PubMed ID: 4267958
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrolyte-dependence of cardiac glycoside actions at the cellular and subcellular level.
    Klaus W; Fricke U
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():393-9. PubMed ID: 145631
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of cardiac glycosides with (Na+ + K+)-activated ATPase. A biochemical link to digitalis-induced inotropy.
    Hansen O
    Pharmacol Rev; 1984 Sep; 36(3):143-63. PubMed ID: 6093155
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
    Tobin T; Akera T; Ku D; Lu MC
    Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.